Multicenter study of serum HER2 monitoring in tissue HER2 positive gastric cancer

Multicenter study of serum HER2 monitoring in tissue HER2 positive gastric cancer - Evaluation of serum HER2 in tissue HER2 positive gastric cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013186

Enrollment

Registered

2014-02-18

Start date

2014-02-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Histologically diagnosed HER2-positive gastric cancer 2.Patients with evaluable lesions 3.Patients before the treatment for gastric cancer

Exclusion criteria

Exclusion criteria: 1. Patients with other active cancers 2. Patients with uncontrolled or severe complications

Design outcomes

Primary

Measure	Time frame
Correlation between the change of serum HER2 and clinical response to treatment	—

Secondary

Measure	Time frame
Comparison of the level of serum HER2 and the other tumor marker	—

Countries

Japan

Contacts

Public ContactKatsunobu Oyama

Kanazawa University Gastroenterologic Surgery

oya-ma@staff.kanazawa-u.ac.jp076-265-2000

Outcome results